Redcare Pharmacy NV (SHPPF)
148.00
0.00 (0.00%)
USD |
OTCM |
May 07, 16:00
Redcare Pharmacy Debt to Equity Ratio: 0.4727 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.4727 |
| December 31, 2023 | 0.3964 |
| September 30, 2023 | 0.4654 |
| June 30, 2023 | 0.5006 |
| March 31, 2023 | 0.7408 |
| December 31, 2022 | 0.6251 |
| September 30, 2022 | 0.7607 |
| June 30, 2022 | 0.7129 |
| March 31, 2022 | 0.6002 |
| December 31, 2021 | 0.495 |
| September 30, 2021 | 0.5652 |
| June 30, 2021 | 0.5502 |
| March 31, 2021 | 0.5421 |
| December 31, 2020 | 0.0097 |
| September 30, 2020 | 0.5663 |
| June 30, 2020 | 0.5626 |
| March 31, 2020 | 0.778 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.6135 |
| September 30, 2019 | 0.0981 |
| June 30, 2019 | 0.088 |
| March 31, 2019 | 0.4378 |
| December 31, 2018 | 0.3811 |
| September 30, 2018 | 0.0212 |
| June 30, 2018 | 0.0209 |
| March 31, 2018 | 0.0183 |
| December 31, 2017 | 0.0305 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.003 |
| September 30, 2016 | 2.492 |
| June 30, 2016 | 3.160 |
| March 31, 2016 | |
| December 31, 2015 | 7.728 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0097
Minimum
Dec 2020
0.778
Maximum
Mar 2020
0.5072
Average
0.5564
Median
Debt to Equity Ratio Benchmarks
| uniQure NV | 0.49 |
| ProQR Therapeutics NV | 0.1037 |
| Merus NV | 0.00 |
| argenx SE | 0.00 |
| Pharming Group | 0.6327 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.094B |
| Total Liabilities (Quarterly) | 507.06M |
| Shareholders Equity (Quarterly) | 556.23M |
| Current Ratio | 2.211 |
| Net Debt Paydown Yield | -0.18% |